MCL1 and hepatocellular carcinoma: We also found that a combination of magnolol and regorafenib may decrease the protein level of MCL-1, compared to the treatments with magnolol or regorafenib alone, in HCC cells in vitro and in vivo (Figure 1G,H and Figure 6G).